REFERÊNCIAS BIBLIOGRÁFICAS
69
KIM Y-K, Kimn S-J, Kramer CM, Yatani A, Takagi G, Mankad S, Szigeti GP, Singh D,
Bishop SP, Shannon RP, Vatner DE, Vatner SF (2002). Altered exitation-contraction
coupling in myocytes from remodeled myocardium after chronic myocardial infarction. J
Mol Cell Cardiol, 34: 63 – 73.
LANNOY LM, Danser AH, Bouhuizer AM, Saxena PR, Schalekamp MA (1998).
Localization and production of angiotensin II in the isolated perfused rat heart.
Hypertension, 31 (5): 1111 – 1117.
L’ ENFANTE C (1998). NHBI at 50 – Reflections on a half century of research on the
heart, lung and blood. National Heart, Lung, and Institute. JAMA, 280: 2060-2064.
LEVINE TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic
nervous system and rennin-angiotensin system assessed by plasma hormone leves and
the relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol, 49
(7): 1659-1666.
LI P, Zhang X, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P (1993). Myosite
loss and left ventricular failure characterise the long term effects of coronary artery
narrowing or hypertension in rats. Cardiovascular Reaserch, 27(6): 1066-1075.
LI Y, Xue Q, Ma J, Zhang C, Qiu P, Wang L, Gao W, Cheng W, Lu Z, Wang S. Effects of
imidapril on heterogeneity of action potential and calcium current of ventricular myocytes
in infarcted rabbits. Acta Pharmacol Sin, 25 (11): 1458 – 1463.
LIDDLE GW, Hardman JG (1971). Cyclic adenosine monophosphate as a mediator of
hormone action. N Engl J Med, 285(10): 560-566.
LINZ W, Wiemer G, Schaper J, Zimmermann R, Nagasawz K, Gohlke P, Unger T,
Scholkens BA (1995). Angiotensin converting enzyme inhibitors, left ventricular
hypertrophy and fibrosis. Molecular and Celular Biochemistry, 147: 89 – 97.